CVS Health Co. (NYSE:CVS) is Gibraltar Capital Management Inc.’s 2nd Largest Position

Gibraltar Capital Management Inc. lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 4.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 154,795 shares of the pharmacy operator’s stock after selling 7,882 shares during the quarter. CVS Health makes up approximately 5.2% of Gibraltar Capital Management Inc.’s portfolio, making the stock its 2nd biggest position. Gibraltar Capital Management Inc.’s holdings in CVS Health were worth $12,223,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. SOA Wealth Advisors LLC. lifted its stake in CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 133 shares during the period. Apella Capital LLC lifted its position in CVS Health by 4.2% during the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after buying an additional 136 shares during the period. Prairie Sky Financial Group LLC lifted its position in CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after buying an additional 141 shares during the period. WealthShield Partners LLC lifted its position in CVS Health by 3.2% during the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after buying an additional 141 shares during the period. Finally, Sugarloaf Wealth Management LLC lifted its position in CVS Health by 9.5% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock valued at $129,000 after buying an additional 142 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS traded up $0.28 during midday trading on Tuesday, reaching $67.73. 13,476,347 shares of the stock traded hands, compared to its average volume of 10,639,692. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a market capitalization of $85.37 billion, a PE ratio of 10.48, a P/E/G ratio of 0.89 and a beta of 0.52. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company’s 50 day moving average is $74.05 and its 200 day moving average is $73.62.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. During the same quarter in the prior year, the firm posted $1.99 EPS. CVS Health’s quarterly revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts anticipate that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.93%. CVS Health’s payout ratio is 41.18%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CVS shares. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. SVB Leerink started coverage on CVS Health in a report on Monday, February 26th. They set an “outperform” rating and a $88.00 price target for the company. Royal Bank of Canada reduced their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $87.00 price objective on shares of CVS Health in a report on Wednesday, April 10th. Finally, Barclays assumed coverage on CVS Health in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price objective for the company. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $89.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.